End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.32 MYR | -0.16% |
|
+0.64% | +4.81% |
12:35pm | Fortis Healthcare Limited Designates Prem Kumar Nair as Vice-Chairman of Board | CI |
Jun. 27 | IHH Healthcare Issues Shares Upon Exercise of Options | MT |
Strengths
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- With an expected P/E ratio at 30.34 and 28.14 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+4.98% | 11.84B | B+ | ||
-36.66% | 12.81B | B+ | ||
-4.50% | 11.5B | B | ||
+10.95% | 10.72B | B+ | ||
+12.65% | 7.14B | B- | ||
-10.66% | 7.24B | A- | ||
+9.12% | 6.5B | D | ||
+10.13% | 4.25B | B+ | ||
+32.50% | 4.09B | - | ||
-9.20% | 4.06B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- IHH Stock
- Ratings IHH Healthcare